Harlan Waksal - 16 Feb 2022 Form 3 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Signature
/s/ Jason Cavalier, Attorney-in-Fact for Harlan Waksal, M.D.
Issuer symbol
LYRA
Transactions as of
16 Feb 2022
Net transactions value
$0
Form type
3
Filing time
18 Feb 2022, 16:08:12 UTC
Previous filing
09 Nov 2021
Next filing
13 Apr 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.